One of the keys to PST success has been the implementation of strategic partnerships and alliances and a flexible and pragmatic approach to licensing and acquisitions. These are fundamental to the company’s continued growth and success.

PST welcomes the US, Japanese and European companies for cooperation to boost a mutual beneficial and fruitful business opportunities and forges broad partnership to develop, register and commercialize its products in Iran’s health ministry (Out- Lenience). Rising the confidence in TPS financial management and our capital resource encourage us to press ahead on a normalization path that consequently has helped us drive up yields in the mutual business. Our Investors no longer need to take on as much risk to generate enough return on their fiscal budgets. Our Investors have piled into safest business in our organization for search of higher their yields and their remarkable dividends.

Our Corporate and Business Development Department is a team of business experts and alliance management pundits who oversee the selection and review of licensing and acquisition opportunities, manage the out-licensing process and actively pursue strategic alliances, to build strong relationships that are mutually beneficial to Co-Partners.

If you are interested in learning more about collaboration opportunities with PST, or to discuss a compound currently in clinical development, please contact our business development team via email at: